Nu Skin Enterprises found using ticker (NUS) now have 5 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The target price ranges between 70 and 43 and has a mean target at 54.2. Given that the stocks previous close was at 41.12 this would imply there is a potential upside of 31.8%. The 50 day MA is 42.79 while the 200 day moving average is 52.37. The market capitalisation for the company is $2,077m. You can visit the company’s website by visiting: http://www.nuskin.com
Nu Skin Enterprises develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises was founded in 1984 and is headquartered in Provo, Utah.
You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.
